Imperva (IMPV) Stock Rating Lowered by J P Morgan Chase & Co

Imperva (NASDAQ:IMPV) was downgraded by J P Morgan Chase & Co from a “neutral” rating to an “underweight” rating in a report released on Tuesday, MarketBeat Ratings reports. They presently have a $45.00 price objective on the software maker’s stock. J P Morgan Chase & Co’s price target indicates a potential upside of 9.62% from the stock’s previous close.

Several other analysts also recently issued reports on IMPV. BidaskClub raised shares of Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, August 22nd. Piper Jaffray Companies set a $58.00 price objective on shares of Imperva and gave the company a “buy” rating in a research report on Monday, August 28th. Zacks Investment Research downgraded shares of Imperva from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 27th. Wells Fargo & Company downgraded shares of Imperva from an “outperform” rating to a “market perform” rating in a research report on Monday, October 9th. Finally, William Blair downgraded shares of Imperva from an “outperform” rating to a “market perform” rating in a research report on Tuesday, October 10th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $51.86.

Shares of Imperva (NASDAQ IMPV) traded up $0.60 during trading hours on Tuesday, reaching $41.05. 810,888 shares of the company’s stock traded hands, compared to its average volume of 257,135. Imperva has a one year low of $37.05 and a one year high of $52.40.

Imperva (NASDAQ:IMPV) last issued its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.11. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The company had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. During the same quarter last year, the company earned $0.08 earnings per share. Imperva’s revenue for the quarter was up 22.6% on a year-over-year basis. equities research analysts forecast that Imperva will post -0.52 EPS for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in IMPV. SG Americas Securities LLC acquired a new stake in shares of Imperva during the third quarter worth approximately $134,000. First Quadrant L P CA acquired a new stake in shares of Imperva during the third quarter worth approximately $136,000. Ameritas Investment Partners Inc. grew its position in shares of Imperva by 18.7% during the second quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after buying an additional 464 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its position in shares of Imperva by 26.2% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after buying an additional 866 shares in the last quarter. Finally, Amalgamated Bank acquired a new stake in shares of Imperva during the second quarter worth approximately $206,000. 96.95% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/17/imperva-impv-stock-rating-lowered-by-j-p-morgan-chase-co.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply